EGM
ATRA icon

Engineers Gate Manager’s Atara Biotherapeutics ATRA Stock Holding History

Engineers Gate Manager’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,192
Closed -$20.7K – 1915
2024
Q1 		$20.7K Sell
1,192
-12
-1% -$213 ﹤0.01% 1840
2023
Q4 		$15.4K Buy
1,204
+639
+113% +$14.9K ﹤0.01% 1918
2023
Q3 		$20.9K Buy
+565
New +$25.1K ﹤0.01% 1705
2022
Q2 		– Sell
-656
Closed -$152K – 1890
2022
Q1 		$152K Sell
656
-1,171
-64% -$373K 0.01% 1659
2021
Q4 		$720K Buy
+1,827
New +$769K 0.03% 808
2021
Q3 		– Sell
-853
Closed -$332K – 1631
2021
Q2 		$332K Sell
853
-533
-38% -$190K 0.02% 1065
2021
Q1 		$498K Buy
1,386
+705
+104% +$312K 0.02% 992
2020
Q4 		$334K Sell
681
-200
-23% -$92.3K 0.01% 1226
2020
Q3 		$286K Buy
+881
New +$300K 0.01% 1276

Other funds holding ATRA

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return